They have the potential to affect the activation of CD4+ and CD8+ T-cells, leading to the negative regulation of the immune response, which makes them attractive targets for the treatment of transplantation and autoimmune diseases [6, 7]. This evidence concerns the gene CD8A and autoimmune disease.